Despite a decline in sales, Boule Diagnostics AB (STU:8BD) reports significant gains in operating profit and margin, driven by strategic restructuring and OEM sales growth.
Despite a dip in net sales, Boule Diagnostics AB (STU:8BD) shows resilience with improved cash flow and strategic cost efficiencies.